Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $8.62 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 43.32.
Market Cap
8.62T
Revenue
4.59T
Profits
199.11B
PE Ratio
43.32
Profit Margin
4.34%
Dividend Yield
0.41%
1059 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 996.31B | 0.92% | 2,885,437 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 580.14B | 0.80% | 7,872,679 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 415.00B | 0.06% | 7,264,198 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 368.52B | -0.84% | 6,798,059 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 297.86B | 0.84% | 9,871,836 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 284.06B | 1.10% | 2,377,554 | 60.44B |
| 7 | NVS | Novartis AG | 280.29B | -0.17% | 7,223,537 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 209.63B | -0.02% | 15,064,908 | 50.57B |
| 9 | AMGN | Amgen Inc. | 189.67B | 1.27% | 2,380,454 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 182.91B | 4.87% | 2,123,958 | 45.20B |
| 11 | ABT | Abbott Laboratories | 157.62B | -0.04% | 13,191,571 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 155.39B | 0.09% | 6,999,343 | 29.74B |
| 13 | ISRG | Intuitive Surgical, Inc. | 142.31B | -0.33% | 2,333,411 | 10.58B |
| 14 | PFE | Pfizer Inc. | 137.01B | -2.75% | 75,709,430 | 63.32B |
| 15 | DHR | Danaher Corporation | 133.68B | 5.53% | 5,570,847 | 24.78B |
| 16 | CVS | CVS Health Corporation | 129.98B | 0.30% | 8,337,252 | 405.62B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 120.61B | 1.45% | 1,520,207 | 12.22B |
| 18 | SYK | Stryker Corporation | 120.25B | 1.19% | 2,756,981 | 25.27B |
| 19 | BMY | Bristol-Myers Squibb Company | 112.31B | -0.95% | 18,292,833 | 48.48B |
| 20 | MDT | Medtronic plc | 102.57B | -0.62% | 8,299,252 | 36.36B |
| 21 | GSK | GSK plc | 102.31B | -1.88% | 3,668,634 | 43.29B |
| 22 | SNY | Sanofi | 100.38B | -0.65% | 7,775,929 | 54.60B |
| 23 | MCK | McKesson Corporation | 89.75B | 0.35% | 1,247,263 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 86.02B | 0.22% | 1,225,952 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 83.39B | -2.81% | 2,104,923 | 200.42B |
| 26 | CI | The Cigna Group | 73.93B | -1.28% | 2,796,928 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 66.08B | -2.50% | 20,706,788 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 63.43B | 0.87% | 837,298 | 14.92B |
| 29 | COR | Cencora, Inc. | 55.35B | 1.20% | 1,633,370 | 328.68B |
| 30 | CAH | Cardinal Health, Inc. | 54.57B | 1.79% | 2,100,603 | 250.74B |
| 31 | ARGX | argenx SE | 52.88B | -0.11% | 661,741 | 4.74B |
| 32 | EW | Edwards Lifesciences Corporation | 51.63B | 3.12% | 4,281,407 | 6.30B |
| 33 | TAK | Takeda Pharmaceutical Company Limited | 49.92B | -0.76% | 2,951,177 | 28.34B |
| 34 | MDLN | Medline Inc. | 47.36B | 2.12% | 6,574,356 | 29.14B |
| 35 | HUM | Humana Inc. | 43.42B | 0.70% | 1,653,703 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 43.32B | 1.45% | 618,264 | 4.45B |
| 37 | BDX | Becton, Dickinson and Company | 40.72B | 2.68% | 2,070,863 | 22.23B |
| 38 | HLN | Haleon plc | 40.39B | 3.13% | 9,669,524 | 14.85B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 39.85B | 3.04% | 6,553,060 | 17.35B |
| 40 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.26B | 2.04% | 1,298,800 | 4.29B |
| 41 | NTRA | Natera, Inc. | 37.23B | 10.74% | 2,563,594 | 2.50B |
| 42 | A | Agilent Technologies, Inc. | 37.18B | 3.92% | 2,538,278 | 7.23B |
| 43 | WAT | Waters Corporation | 36.25B | 3.35% | 903,957 | 3.77B |
| 44 | RVMD | Revolution Medicines, Inc. | 36.09B | 0.15% | 3,625,390 | - |
| 45 | ALC | Alcon Inc. | 33.26B | 2.74% | 1,558,290 | 10.63B |
| 46 | ZTS | Zoetis Inc. | 32.77B | 1.73% | 4,703,443 | 9.53B |
| 47 | RPRX | Royalty Pharma plc | 31.26B | -1.93% | 4,243,184 | 2.44B |
| 48 | CNC | Centene Corporation | 31.09B | -0.27% | 5,127,111 | 178.33B |
| 49 | IQV | IQVIA Holdings Inc. | 30.98B | 8.37% | 1,813,371 | 16.63B |
| 50 | ONC | BeOne Medicines AG | 30.81B | 0.36% | 201,205 | 5.70B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 29.51B | 1.82% | 3,928,056 | 20.98B |
| 52 | BIIB | Biogen Inc. | 29.47B | 1.22% | 1,281,803 | 9.94B |
| 53 | RMD | ResMed Inc. | 28.38B | 2.74% | 1,438,894 | 5.54B |
| 54 | DXCM | DexCom, Inc. | 26.91B | 1.20% | 2,976,675 | 4.82B |
| 55 | ILMN | Illumina, Inc. | 26.49B | 6.16% | 2,643,643 | 4.39B |
| 56 | VEEV | Veeva Systems Inc. | 26.21B | 1.03% | 2,515,225 | 3.32B |
| 57 | PHG | Koninklijke Philips N.V. | 25.56B | 0.45% | 1,190,310 | 20.34B |
| 58 | ROIV | Roivant Sciences Ltd. | 24.46B | 5.59% | 10,302,370 | 8.26M |
| 59 | MTD | Mettler-Toledo International Inc. | 24.31B | 4.02% | 278,095 | 4.09B |
| 60 | WST | West Pharmaceutical Services, Inc. | 24.05B | 1.20% | 671,344 | 3.22B |
| 61 | MRNA | Moderna, Inc. | 23.97B | -0.95% | 5,135,535 | 2.23B |
| 62 | UTHR | United Therapeutics Corporation | 23.34B | 1.02% | 338,743 | 3.17B |
| 63 | BNTX | BioNTech SE | 22.81B | -0.45% | 1,440,591 | 3.23B |
| 64 | DGX | Quest Diagnostics Incorporated | 22.48B | 3.01% | 1,032,820 | 11.28B |
| 65 | INSM | Insmed Incorporated | 22.43B | 1.28% | 3,107,998 | 819.56M |
| 66 | LH | Labcorp Holdings Inc. | 21.74B | 2.55% | 621,357 | 14.14B |
| 67 | INCY | Incyte Corporation | 21.67B | 3.89% | 1,931,912 | 5.36B |
| 68 | STE | STERIS plc | 20.19B | 1.95% | 701,237 | 5.94B |
| 69 | VTRS | Viatris Inc. | 18.55B | 1.14% | 8,985,538 | 14.56B |
| 70 | GH | Guardant Health, Inc. | 18.16B | 4.69% | 3,439,119 | 1.08B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 17.52B | 3.41% | 2,048,433 | 8.41B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 16.70B | 2.86% | 1,361,969 | 3.10B |
| 73 | GMAB | Genmab A/S | 15.91B | -0.29% | 1,376,296 | 3.90B |
| 74 | THC | Tenet Healthcare Corporation | 15.76B | 1.15% | 1,079,961 | 21.46B |
| 75 | ASND | Ascendis Pharma A/S | 14.78B | -0.24% | 476,277 | 998.25M |
| 76 | MEDP | Medpace Holdings, Inc. | 14.65B | 8.30% | 503,481 | 2.68B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 14.42B | -0.17% | 742,354 | 4.44B |
| 78 | BTSG | BrightSpring Health Services, Inc. | 14.08B | 1.15% | 2,874,149 | 13.65B |
| 79 | DVA | DaVita Inc. | 13.68B | 1.00% | 493,905 | 13.84B |
| 80 | BBIO | BridgeBio Pharma, Inc. | 13.58B | 1.06% | 4,190,317 | 579.96M |
| 81 | COO | The Cooper Companies, Inc. | 13.42B | 4.05% | 3,496,507 | 4.23B |
| 82 | EXEL | Exelixis, Inc. | 13.29B | 2.98% | 2,931,388 | 2.38B |
| 83 | SOLV | Solventum Corporation | 13.09B | 2.16% | 1,168,789 | 8.26B |
| 84 | SNN | Smith & Nephew plc | 12.87B | 2.20% | 1,384,726 | 6.16B |
| 85 | FMS | Fresenius Medical Care AG | 12.86B | 0.63% | 550,055 | 22.32B |
| 86 | IONS | Ionis Pharmaceuticals, Inc. | 12.65B | 0.70% | 2,126,814 | 1.06B |
| 87 | PEN | Penumbra, Inc. | 12.44B | -0.40% | 247,477 | 1.45B |
| 88 | AXSM | Axsome Therapeutics, Inc. | 12.24B | -1.67% | 1,041,164 | 708.24M |
| 89 | ALGN | Align Technology, Inc. | 12.24B | 1.43% | 1,487,294 | 4.10B |
| 90 | ICLR | ICON Public Limited Company | 12.11B | 10.86% | 2,406,383 | 8.27B |
| 91 | ELAN | Elanco Animal Health Incorporated | 11.97B | 3.36% | 3,953,755 | 4.89B |
| 92 | RVTY | Revvity, Inc. | 11.78B | 5.74% | 1,631,674 | 2.90B |
| 93 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.75B | -0.71% | 399,750 | 1.13B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 11.73B | 2.45% | 3,528,575 | 3.58B |
| 95 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.24B | -0.11% | 2,047,837 | 622.01M |
| 96 | GMED | Globus Medical, Inc. | 11.15B | 2.60% | 1,806,551 | 3.10B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 11.08B | 1.47% | 1,597,154 | 3.24B |
| 98 | SMMT | Summit Therapeutics Inc. | 11.06B | - | 6,767,425 | - |
| 99 | CYTK | Cytokinetics, Incorporated | 11.02B | 1.49% | 2,425,586 | 105.82M |
| 100 | BAX | Baxter International Inc. | 10.87B | 4.68% | 6,065,026 | 11.32B |
| 101 | MOH | Molina Healthcare, Inc. | 10.49B | 2.47% | 865,980 | 43.10B |
| 102 | PODD | Insulet Corporation | 10.31B | 3.46% | 1,385,667 | 2.90B |
| 103 | KRYS | Krystal Biotech, Inc. | 10.25B | 2.18% | 373,295 | 417.30M |
| 104 | EHC | Encompass Health Corporation | 10.14B | 2.35% | 1,240,942 | 6.07B |
| 105 | APGE | Apogee Therapeutics, Inc. | 9.94B | -0.14% | 7,120,937 | - |
| 106 | NUVL | Nuvalent, Inc. | 9.76B | 0.11% | 2,420,574 | - |
| 107 | CRL | Charles River Laboratories International, Inc. | 9.73B | 8.31% | 936,620 | 4.03B |
| 108 | ENSG | The Ensign Group, Inc. | 9.51B | 3.26% | 999,432 | 5.27B |
| 109 | HSIC | Henry Schein, Inc. | 9.43B | 3.40% | 1,099,860 | 13.38B |
| 110 | TEM | Tempus AI, Inc. | 9.33B | 6.85% | 6,881,123 | 1.36B |
| 111 | TECH | Bio-Techne Corporation | 9.22B | 4.65% | 4,186,307 | 1.21B |
| 112 | BRKR | Bruker Corporation | 8.90B | 6.04% | 1,843,809 | 3.46B |
| 113 | UHS | Universal Health Services, Inc. | 8.80B | -0.30% | 595,215 | 17.76B |
| 114 | OSCR | Oscar Health, Inc. | 8.78B | -2.57% | 4,736,284 | 13.30B |
| 115 | CORT | Corcept Therapeutics Incorporated | 8.76B | 2.14% | 753,885 | 769.10M |
| 116 | PRAX | Praxis Precision Medicines, Inc. | 8.61B | 1.17% | 516,828 | 7.46M |
| 117 | HALO | Halozyme Therapeutics, Inc. | 8.44B | 2.20% | 1,937,497 | 1.51B |
| 118 | ALKS | Alkermes plc | 8.41B | 4.95% | 3,725,837 | 1.56B |
| 119 | KYMR | Kymera Therapeutics, Inc. | 8.22B | 1.65% | 1,302,181 | 51.48M |
| 120 | IBRX | ImmunityBio, Inc. | 8.17B | 6.56% | 14,447,829 | 140.98M |
| 121 | GKOS | Glaukos Corporation | 8.09B | 2.31% | 634,495 | 551.35M |
| 122 | QGEN | Qiagen N.V. | 8.01B | 4.11% | 2,456,526 | 2.10B |
| 123 | ATR | AptarGroup, Inc. | 7.93B | 3.04% | 384,910 | 3.87B |
| 124 | PTGX | Protagonist Therapeutics, Inc. | 7.85B | 2.64% | 1,122,324 | 74.06M |
| 125 | IMVT | Immunovant, Inc. | 7.85B | 1.59% | 1,535,668 | - |
| 126 | RGEN | Repligen Corporation | 7.81B | 9.52% | 1,372,709 | 763.34M |
| 127 | PCVX | Vaxcyte, Inc. | 7.78B | 3.68% | 2,033,406 | - |
| 128 | TGTX | TG Therapeutics, Inc. | 7.60B | -0.63% | 2,707,148 | 700.35M |
| 129 | HIMS | Hims & Hers Health, Inc. | 7.57B | -0.79% | 12,589,439 | 2.37B |
| 130 | BIO | Bio-Rad Laboratories, Inc. | 7.49B | 3.60% | 316,054 | 2.59B |
| 131 | SYRE | Spyre Therapeutics, Inc. | 7.49B | -11.14% | 4,035,695 | - |
| 132 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.37B | 1.28% | 1,226,419 | 217.17M |
| 133 | ABVX | ABIVAX Société Anonyme | 7.31B | -6.01% | 6,611,228 | 5.67M |
| 134 | HQY | HealthEquity, Inc. | 7.11B | 0.09% | 685,465 | 1.34B |
| 135 | MIRM | Mirum Pharmaceuticals, Inc. | 7.01B | 3.51% | 969,087 | 569.61M |
| 136 | PTCT | PTC Therapeutics, Inc. | 7.00B | 2.78% | 3,320,389 | 827.11M |
| 137 | LNTH | Lantheus Holdings, Inc. | 6.83B | -1.11% | 706,026 | 1.55B |
| 138 | LQDA | Liquidia Corporation | 6.72B | 2.03% | 2,085,637 | 288.07M |
| 139 | AVTR | Avantor, Inc. | 6.62B | 2.76% | 7,910,273 | 6.55B |
| 140 | COGT | Cogent Biosciences, Inc. | 6.41B | 3.36% | 4,948,387 | - |
| 141 | SRRK | Scholar Rock Holding Corporation | 6.27B | 2.07% | 2,459,656 | - |
| 142 | CNTA | Centessa Pharmaceuticals plc | 6.27B | - | - | 15.00M |
| 143 | GRFS | Grifols, S.A. | 6.17B | 0.56% | 805,341 | 8.58B |
| 144 | PACS | PACS Group, Inc. | 6.15B | 3.96% | 1,234,141 | 5.43B |
| 145 | CGON | CG Oncology, Inc. | 6.06B | 4.55% | 1,507,331 | 5.07M |
| 146 | BLTE | Belite Bio, Inc | 5.93B | 3.91% | 274,700 | - |
| 147 | CHE | Chemed Corporation | 5.91B | 0.72% | 211,724 | 2.54B |
| 148 | LGND | Ligand Pharmaceuticals Incorporated | 5.71B | 1.96% | 476,159 | 274.48M |
| 149 | TWST | Twist Bioscience Corporation | 5.69B | 7.47% | 2,095,761 | 409.48M |
| 150 | TFX | Teleflex Incorporated | 5.60B | 1.81% | 220,081 | 2.13B |
| 151 | BLCO | Bausch + Lomb Corporation | 5.53B | 1.77% | 244,009 | 5.21B |
| 152 | AMRX | Amneal Pharmaceuticals, Inc. | 5.51B | 3.66% | 1,666,044 | 3.05B |
| 153 | HNGE | Hinge Health, Inc. | 5.46B | 0.26% | 1,905,391 | 646.34M |
| 154 | LEGN | Legend Biotech Corporation | 5.46B | 0.27% | 1,935,179 | 1.14B |
| 155 | XENE | Xenon Pharmaceuticals Inc. | 5.37B | 1.78% | 1,425,054 | 7.50M |
| 156 | TVTX | Travere Therapeutics, Inc. | 5.36B | 3.11% | 2,447,729 | 536.20M |
| 157 | CRSP | CRISPR Therapeutics AG | 5.16B | -0.81% | 1,408,167 | 4.10M |
| 158 | CAI | Caris Life Sciences, Inc. | 5.13B | 3.12% | 2,163,673 | 907.29M |
| 159 | INDV | Indivior Pharmaceuticals, Inc. | 5.06B | 3.78% | 1,945,144 | 1.29B |
| 160 | DNTH | Dianthus Therapeutics, Inc. | 4.96B | 3.74% | 1,520,700 | 1.34M |
| 161 | BLLN | BillionToOne, Inc. | 4.96B | 3.32% | 1,161,759 | 354.54M |
| 162 | ORKA | Oruka Therapeutics, Inc. | 4.95B | -1.57% | 1,640,810 | - |
| 163 | MANE | Veradermics, Incorporated | 4.90B | 13.21% | 1,039,822 | - |
| 164 | SHC | Sotera Health Company | 4.76B | 5.37% | 3,991,892 | 1.19B |
| 165 | STVN | Stevanato Group S.p.A. | 4.71B | 2.19% | 419,368 | 1.39B |
| 166 | CELC | Celcuity Inc. | 4.70B | 6.84% | 1,042,010 | - |
| 167 | ERAS | Erasca, Inc. | 4.68B | -0.13% | 4,122,129 | - |
| 168 | DFTX | Definium Therapeutics, Inc. | 4.59B | 16.45% | 12,457,985 | - |
| 169 | RDNT | RadNet, Inc. | 4.57B | 3.49% | 902,446 | 2.14B |
| 170 | EWTX | Edgewise Therapeutics, Inc. | 4.55B | 8.94% | 1,339,116 | - |
| 171 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.55B | -0.61% | 1,049,076 | 754.05M |
| 172 | VCYT | Veracyte, Inc. | 4.53B | 5.52% | 1,294,310 | 541.74M |
| 173 | ALHC | Alignment Healthcare, Inc. | 4.48B | 0.14% | 2,801,090 | 4.26B |
| 174 | VKTX | Viking Therapeutics, Inc. | 4.40B | 8.79% | 5,137,810 | - |
| 175 | TXG | 10x Genomics, Inc. | 4.39B | 8.57% | 2,585,893 | 638.78M |
| 176 | LIVN | LivaNova PLC | 4.39B | 1.61% | 666,647 | 1.43B |
| 177 | RGC | Regencell Bioscience Holdings Limited | 4.24B | -22.74% | 436,113 | - |
| 178 | NVST | Envista Holdings Corporation | 4.24B | 3.09% | 2,338,424 | 2.81B |
| 179 | TNGX | Tango Therapeutics, Inc. | 4.21B | 2.57% | 4,762,356 | 56.99M |
| 180 | MMSI | Merit Medical Systems, Inc. | 4.13B | 2.87% | 687,441 | 1.54B |
| 181 | ACAD | ACADIA Pharmaceuticals Inc. | 4.00B | 3.36% | 1,495,660 | 1.10B |
| 182 | MMED | MiniMed Group, Inc. | 3.97B | 2.84% | 1,111,715 | 3.10B |
| 183 | DNLI | Denali Therapeutics Inc. | 3.94B | 0.20% | 1,493,591 | - |
| 184 | RLAY | Relay Therapeutics, Inc. | 3.93B | 3.33% | 4,593,195 | 10.68M |
| 185 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | 0.06% | 1,179,580 | 596.96M |
| 186 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.81B | 0.75% | 1,738,113 | 18.07M |
| 187 | NAMS | NewAmsterdam Pharma Company N.V. | 3.81B | 3.92% | 1,235,518 | 22.57M |
| 188 | DOCS | Doximity, Inc. | 3.81B | 1.71% | 3,365,534 | 644.86M |
| 189 | LFST | LifeStance Health Group, Inc. | 3.74B | 2.22% | 2,821,159 | 1.49B |
| 190 | CON | Concentra Group Holdings Parent, Inc. | 3.73B | 1.67% | 565,131 | 2.23B |
| 191 | IRTC | iRhythm Holdings, Inc. | 3.70B | 2.13% | 482,867 | 787.85M |
| 192 | TLX | Telix Pharmaceuticals Limited | 3.68B | 6.76% | 194,923 | 803.79M |
| 193 | WAY | Waystar Holding Corp. | 3.64B | 3.20% | 2,703,528 | 1.16B |
| 194 | RCUS | Arcus Biosciences, Inc. | 3.62B | 2.20% | 1,784,876 | 236.00M |
| 195 | ICUI | ICU Medical, Inc. | 3.57B | 5.48% | 234,691 | 2.16B |
| 196 | OGN | Organon & Co. | 3.54B | 0.22% | 3,024,433 | 6.16B |
| 197 | BKD | Brookdale Senior Living Inc. | 3.51B | 6.14% | 6,846,527 | 3.00B |
| 198 | PBLS | Parabilis Medicines, Inc. | 3.48B | -0.69% | 599,784 | - |
| 199 | OPCH | Option Care Health, Inc. | 3.46B | 0.18% | 1,807,148 | 5.67B |
| 200 | ARQT | Arcutis Biotherapeutics, Inc. | 3.42B | 4.19% | 2,055,532 | 415.62M |
| 201 | GPCR | Structure Therapeutics Inc. | 3.42B | 5.59% | 665,131 | - |
| 202 | BEAM | Beam Therapeutics Inc. | 3.37B | 2.11% | 3,032,104 | 164.01M |
| 203 | DYN | Dyne Therapeutics, Inc. | 3.36B | 0.35% | 2,185,369 | - |
| 204 | HAE | Haemonetics Corporation | 3.31B | 0.12% | 359,905 | 1.33B |
| 205 | WRBY | Warby Parker Inc. | 3.29B | 4.72% | 3,203,162 | 890.57M |
| 206 | IDYA | IDEAYA Biosciences, Inc. | 3.19B | 3.92% | 1,472,874 | 225.27M |
| 207 | ALMS | Alumis Inc. | 3.17B | 1.39% | 956,311 | 8.40M |
| 208 | NHC | National HealthCare Corporation | 3.17B | 1.64% | 86,591 | 1.53B |
| 209 | ITGR | Integer Holdings Corporation | 3.10B | 2.05% | 246,952 | 1.86B |
| 210 | ADPT | Adaptive Biotechnologies Corporation | 3.10B | 12.25% | 4,886,887 | 295.41M |
| 211 | PRVA | Privia Health Group, Inc. | 3.09B | 3.24% | 674,307 | 2.25B |
| 212 | QURE | uniQure N.V. | 3.08B | -0.39% | 4,705,542 | 18.09M |
| 213 | HTFL | HeartFlow, Inc. | 3.01B | 1.25% | 1,687,682 | 191.42M |
| 214 | ELVN | Enliven Therapeutics, Inc. | 2.91B | -1.71% | 2,518,518 | - |
| 215 | TARS | Tarsus Pharmaceuticals, Inc. | 2.89B | 1.42% | 903,792 | 535.08M |
| 216 | RARE | Ultragenyx Pharmaceutical Inc. | 2.86B | 1.22% | 1,705,312 | 670.00M |
| 217 | VERA | Vera Therapeutics, Inc. | 2.84B | 3.43% | 2,473,781 | - |
| 218 | GRAL | GRAIL, Inc. | 2.77B | 5.68% | 628,433 | 156.12M |
| 219 | KLRA | Kailera Therapeutics, Inc. | 2.77B | 0.05% | 473,913 | - |
| 220 | CLOV | Clover Health Investments, Corp. | 2.74B | 2.96% | 8,255,662 | 2.21B |
| 221 | IRON | Disc Medicine, Inc. | 2.69B | -0.11% | 1,220,474 | - |
| 222 | TMDX | TransMedics Group, Inc. | 2.68B | 5.13% | 964,587 | 635.89M |
| 223 | CLDX | Celldex Therapeutics, Inc. | 2.65B | 2.43% | 1,225,689 | 865.00K |
| 224 | SUPN | Supernus Pharmaceuticals, Inc. | 2.62B | 1.48% | 635,441 | 776.83M |
| 225 | ESTA | Establishment Labs Holdings Inc. | 2.57B | 0.23% | 789,004 | 229.58M |
| 226 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.54B | 7.41% | 8,488,286 | 885.72M |
| 227 | TRVI | Trevi Therapeutics, Inc. | 2.49B | 0.81% | 1,722,820 | - |
| 228 | GRDN | Guardian Pharmacy Services, Inc. | 2.43B | -2.19% | 368,086 | 1.46B |
| 229 | AUPH | Aurinia Pharmaceuticals Inc. | 2.39B | 4.14% | 3,231,706 | 298.30M |
| 230 | PHVS | Pharvaris N.V. | 2.33B | 0.30% | 416,148 | - |
| 231 | MBX | MBX Biosciences, Inc. | 2.30B | 4.33% | 854,465 | - |
| 232 | ACHC | Acadia Healthcare Company, Inc. | 2.30B | 1.71% | 2,678,947 | 3.37B |
| 233 | AXGN | Axogen, Inc. | 2.26B | -4.86% | 1,955,946 | 238.11M |
| 234 | BHVN | Biohaven Ltd. | 2.25B | 1.22% | 2,258,050 | - |
| 235 | NUVB | Nuvation Bio Inc. | 2.25B | 6.95% | 8,669,916 | 143.05M |
| 236 | KOD | Kodiak Sciences Inc. | 2.25B | -2.83% | 636,382 | - |
| 237 | PBH | Prestige Consumer Healthcare Inc. | 2.24B | 2.76% | 437,885 | 1.09B |
| 238 | IMNM | Immunome, Inc. | 2.24B | 2.17% | 1,531,409 | 4.02M |
| 239 | NKTR | Nektar Therapeutics | 2.19B | -2.77% | 894,170 | 55.63M |
| 240 | NTLA | Intellia Therapeutics, Inc. | 2.17B | 1.64% | 3,607,085 | 66.09M |
| 241 | AGIO | Agios Pharmaceuticals, Inc. | 2.16B | 1.94% | 1,027,952 | 66.05M |
| 242 | OCUL | Ocular Therapeutix, Inc. | 2.16B | -2.62% | 2,764,079 | 52.04M |
| 243 | VCEL | Vericel Corporation | 2.13B | 3.22% | 779,644 | 292.09M |
| 244 | MLYS | Mineralys Therapeutics, Inc. | 2.13B | 0.64% | 1,280,326 | - |
| 245 | LMAT | LeMaitre Vascular, Inc. | 2.11B | 0.33% | 170,003 | 256.28M |
| 246 | XRAY | DENTSPLY SIRONA Inc. | 2.11B | 3.14% | 4,795,579 | 3.68B |
| 247 | PGNY | Progyny, Inc. | 2.11B | 0.98% | 635,987 | 1.29B |
| 248 | ASTH | Astrana Health, Inc. | 2.10B | 2.60% | 739,857 | 3.53B |
| 249 | GENB | Generate Biomedicines, Inc. | 2.08B | 5.18% | 669,785 | 30.30M |
| 250 | ZLAB | Zai Lab Limited | 2.06B | -0.65% | 1,131,534 | 453.28M |
| 251 | SEM | Select Medical Holdings Corporation | 2.05B | 0.06% | 874,591 | 5.52B |
| 252 | BFLY | Butterfly Network, Inc. | 2.03B | 1.30% | 9,430,363 | 102.92M |
| 253 | ADMA | ADMA Biologics, Inc. | 2.02B | 0.12% | 2,496,861 | 509.86M |
| 254 | NEOG | Neogen Corporation | 2.00B | 3.96% | 1,122,833 | 870.56M |
| 255 | NRIX | Nurix Therapeutics, Inc. | 2.00B | 2.33% | 1,349,864 | 71.78M |
| 256 | HRMY | Harmony Biosciences Holdings, Inc. | 1.99B | 0.85% | 864,226 | 899.11M |
| 257 | TSHA | Taysha Gene Therapies, Inc. | 1.99B | 1.17% | 2,032,387 | 7.47M |
| 258 | MESO | Mesoblast Limited | 1.99B | 1.11% | 149,683 | 65.38M |
| 259 | SGRY | Surgery Partners, Inc. | 1.97B | 4.75% | 1,057,499 | 3.34B |
| 260 | KARD | Kardigan, Inc. | 1.97B | -0.94% | 471,718 | - |
| 261 | MD | Pediatrix Medical Group, Inc. | 1.94B | 1.51% | 630,787 | 1.93B |
| 262 | PGEN | Precigen, Inc. | 1.93B | 0.75% | 4,333,020 | 31.60M |
| 263 | RAPP | Rapport Therapeutics, Inc. | 1.91B | 2.88% | 657,508 | 20.00M |
| 264 | VRDN | Viridian Therapeutics, Inc. | 1.91B | 0.23% | 1,268,893 | 70.92M |
| 265 | LKFT | Lakefront Biotherapeutics NV | 1.90B | -0.28% | 153,109 | 1.20B |
| 266 | IOVA | Iovance Biotherapeutics, Inc. | 1.90B | -4.28% | 14,493,784 | 285.61M |
| 267 | STOK | Stoke Therapeutics, Inc. | 1.89B | -2.31% | 657,490 | 32.08M |
| 268 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.89B | 3.85% | 1,510,469 | -665.00K |
| 269 | WGS | GeneDx Holdings Corp. | 1.89B | 9.40% | 1,444,952 | 442.68M |
| 270 | UFPT | UFP Technologies, Inc. | 1.88B | 3.61% | 215,090 | 608.85M |
| 271 | BHC | Bausch Health Companies Inc. | 1.86B | 3.96% | 2,294,148 | 10.53B |
| 272 | PVLA | Palvella Therapeutics, Inc. | 1.86B | 9.22% | 290,032 | - |
| 273 | SION | Sionna Therapeutics, Inc. | 1.86B | 3.06% | 503,119 | - |
| 274 | AVAH | Aveanna Healthcare Holdings Inc. | 1.84B | 3.29% | 2,296,459 | 2.52B |
| 275 | ABCL | AbCellera Biologics Inc. | 1.84B | 7.10% | 12,685,065 | 79.21M |
| 276 | HCM | HUTCHMED (China) Limited | 1.81B | 1.08% | 26,304 | 548.51M |
| 277 | TYRA | Tyra Biosciences, Inc. | 1.81B | 1.03% | 454,022 | - |
| 278 | SNDA | Sonida Senior Living, Inc. | 1.80B | 5.29% | 1,414,713 | 367.34M |
| 279 | OMCL | Omnicell, Inc. | 1.80B | 2.81% | 515,248 | 1.23B |
| 280 | AGL | agilon health, inc. | 1.78B | -4.27% | 379,243 | 5.82B |
| 281 | ADUS | Addus HomeCare Corporation | 1.78B | 1.16% | 117,306 | 1.45B |
| 282 | ZYME | Zymeworks Inc. | 1.77B | 1.76% | 431,952 | 81.26M |
| 283 | PLSE | Pulse Biosciences, Inc. | 1.77B | -1.35% | 294,549 | 751.00K |
| 284 | SNDX | Syndax Pharmaceuticals, Inc. | 1.77B | 1.89% | 2,261,071 | 217.17M |
| 285 | SRPT | Sarepta Therapeutics, Inc. | 1.76B | -3.27% | 2,398,317 | 2.18B |
| 286 | GLUE | Monte Rosa Therapeutics, Inc. | 1.76B | 0.68% | 2,292,885 | 42.95M |
| 287 | ANIP | ANI Pharmaceuticals, Inc. | 1.75B | -0.27% | 244,001 | 923.71M |
| 288 | INVA | Innoviva, Inc. | 1.74B | 0.38% | 841,152 | 420.69M |
| 289 | NBTX | Nanobiotix S.A. | 1.74B | -6.15% | 84,865 | 38.27M |
| 290 | URGN | UroGen Pharma Ltd. | 1.73B | 0.77% | 462,184 | 140.49M |
| 291 | RXRX | Recursion Pharmaceuticals, Inc. | 1.71B | 2.22% | 15,389,986 | 66.41M |
| 292 | CAPR | Capricor Therapeutics, Inc. | 1.71B | -0.30% | 802,898 | 11.13M |
| 293 | SLS | SELLAS Life Sciences Group, Inc. | 1.71B | 1.10% | 4,527,570 | - |
| 294 | NVCR | NovoCure Limited | 1.70B | 4.18% | 1,522,068 | 674.41M |
| 295 | ANAB | AnaptysBio, Inc. | 1.70B | -1.60% | 479,648 | 232.39M |
| 296 | CMPS | COMPASS Pathways plc | 1.70B | -0.55% | 4,092,401 | - |
| 297 | GHRS | GH Research PLC | 1.69B | 4.19% | 169,006 | - |
| 298 | BCAX | Bicara Therapeutics Inc. | 1.68B | 2.56% | 851,645 | - |
| 299 | NEO | NeoGenomics, Inc. | 1.68B | 12.47% | 6,123,996 | 745.97M |
| 300 | VIR | Vir Biotechnology, Inc. | 1.68B | -2.07% | 2,368,151 | 65.50M |
| 301 | ALMR | Alamar Biosciences, Inc. | 1.65B | 3.88% | 256,591 | 87.16M |
| 302 | TRLV | Trulieve Cannabis Corp. | 1.63B | -0.35% | 2,693,235 | 1.17B |
| 303 | SEPN | Septerna, Inc. | 1.62B | -1.42% | 357,453 | 72.26M |
| 304 | HCSG | Healthcare Services Group, Inc. | 1.62B | 4.11% | 882,726 | 1.85B |
| 305 | FTRE | Fortrea Holdings Inc. | 1.61B | 3.40% | 2,467,884 | 2.71B |
| 306 | HROW | Harrow, Inc. | 1.59B | -0.23% | 793,680 | 268.68M |
| 307 | AKTS | Aktis Oncology, Inc. | 1.59B | 6.26% | 462,030 | 8.28M |
| 308 | ABSI | Absci Corporation | 1.57B | 35.96% | 37,462,827 | 1.84M |
| 309 | ATAI | AtaiBeckley Inc. | 1.54B | 1.71% | 4,982,121 | 3.49M |
| 310 | ARDX | Ardelyx, Inc. | 1.53B | 0.16% | 2,379,003 | 427.68M |
| 311 | IMCR | Immunocore Holdings plc | 1.53B | 2.71% | 1,557,096 | 412.81M |
| 312 | AAPG | Ascentage Pharma Group International | 1.49B | 0.41% | 5,844 | 82.08M |
| 313 | AVBP | ArriVent BioPharma, Inc. | 1.49B | -5.10% | 900,491 | - |
| 314 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.49B | 7.26% | 3,246,377 | 204.73M |
| 315 | SVRA | Savara Inc. | 1.48B | 0.87% | 1,612,336 | - |
| 316 | MAZE | Maze Therapeutics, Inc. | 1.48B | 0.98% | 657,539 | 20.00M |
| 317 | MLTX | MoonLake Immunotherapeutics | 1.47B | -5.75% | 5,474,327 | - |
| 318 | NVAX | Novavax, Inc. | 1.46B | -1.11% | 3,091,166 | 596.34M |
| 319 | STAA | STAAR Surgical Company | 1.44B | 1.97% | 505,558 | 290.38M |
| 320 | ATRC | AtriCure, Inc. | 1.43B | -0.56% | 983,317 | 552.16M |
| 321 | TDOC | Teladoc Health, Inc. | 1.41B | 1.56% | 3,293,576 | 2.51B |
| 322 | CDNA | CareDx, Inc. | 1.40B | 8.00% | 1,369,023 | 412.82M |
| 323 | INBX | Inhibrx Biosciences, Inc. | 1.40B | 2.40% | 316,199 | 1.30M |
| 324 | MPLT | MapLight Therapeutics, Inc. | 1.39B | 7.02% | 386,237 | - |
| 325 | IART | Integra LifeSciences Holdings Corporation | 1.38B | 0.51% | 577,561 | 1.64B |
| 326 | ZBIO | Zenas BioPharma, Inc. | 1.38B | 7.89% | 788,343 | 10.00M |
| 327 | IMTX | Immatics N.V. | 1.37B | 1.11% | 507,545 | 43.00M |
| 328 | DMRA | Damora Therapeutics, Inc. | 1.35B | -4.32% | 412,067 | - |
| 329 | PRGO | Perrigo Company plc | 1.35B | 2.85% | 2,743,996 | 4.18B |
| 330 | ARDT | Ardent Health, Inc. | 1.35B | 2.40% | 470,889 | 6.43B |
| 331 | COAG | Hemab Therapeutics Holdings, Inc. | 1.34B | -1.61% | 134,975 | - |
| 332 | ATEC | Alphatec Holdings, Inc. | 1.34B | 2.35% | 6,780,241 | 787.08M |
| 333 | AHCO | AdaptHealth Corp. | 1.34B | 3.40% | 2,029,962 | 3.29B |
| 334 | INNV | InnovAge Holding Corp. | 1.31B | 3.38% | 420,454 | 949.17M |
| 335 | JBIO | Jade Biosciences, Inc. | 1.30B | -0.32% | 1,235,879 | - |
| 336 | KMTS | Kestra Medical Technologies, Ltd. | 1.29B | 6.72% | 311,421 | 83.72M |
| 337 | XERS | Xeris Biopharma Holdings, Inc. | 1.28B | 2.78% | 1,719,188 | 314.85M |
| 338 | PAHC | Phibro Animal Health Corporation | 1.27B | 2.72% | 206,999 | 1.50B |
| 339 | AVLN | Avalyn Pharma Inc. | 1.26B | -6.53% | 217,059 | - |
| 340 | BLFS | BioLife Solutions, Inc. | 1.25B | 3.15% | 937,872 | 101.66M |
| 341 | INSP | Inspire Medical Systems, Inc. | 1.24B | 3.47% | 804,074 | 915.25M |
| 342 | ALVO | Alvotech | 1.24B | - | 785,246 | 562.04M |
| 343 | ENOV | Enovis Corporation | 1.23B | 1.09% | 1,184,831 | 2.28B |
| 344 | AMN | AMN Healthcare Services, Inc. | 1.23B | 1.54% | 989,210 | 3.42B |
| 345 | IRMD | IRADIMED CORPORATION | 1.21B | 2.49% | 90,329 | 86.28M |
| 346 | EYPT | EyePoint, Inc. | 1.21B | 0.14% | 894,958 | 7.61M |
| 347 | PNTG | The Pennant Group, Inc. | 1.20B | 1.02% | 259,552 | 1.02B |
| 348 | PSNL | Personalis, Inc. | 1.19B | 12.92% | 5,757,915 | 64.52M |
| 349 | PRCT | PROCEPT BioRobotics Corporation | 1.19B | 1.21% | 1,831,127 | 322.02M |
| 350 | MNKD | MannKind Corporation | 1.19B | -2.29% | 4,481,435 | 360.78M |
| 351 | AVNS | Avanos Medical, Inc. | 1.17B | 0.08% | 1,039,977 | 715.90M |
| 352 | AHG | Akso Health Group | 1.16B | -0.74% | 9,151 | 14.84M |
| 353 | COLL | Collegium Pharmaceutical, Inc. | 1.15B | 2.77% | 352,712 | 796.33M |
| 354 | SDGR | Schrödinger, Inc. | 1.15B | 1.93% | 881,705 | 254.91M |
| 355 | WVE | Wave Life Sciences Ltd. | 1.14B | -1.49% | 3,920,258 | 71.80M |
| 356 | OPK | OPKO Health, Inc. | 1.13B | 2.05% | 2,369,517 | 581.12M |
| 357 | OMDA | Omada Health, Inc. | 1.11B | 1.64% | 706,804 | 283.30M |
| 358 | AZTA | Azenta, Inc. | 1.10B | 7.48% | 389,761 | 596.48M |
| 359 | CRVS | Corvus Pharmaceuticals, Inc. | 1.09B | 2.53% | 1,043,350 | - |
| 360 | CGEM | Cullinan Therapeutics, Inc. | 1.08B | -0.56% | 1,442,899 | - |
| 361 | MGTX | MeiraGTx Holdings plc | 1.07B | -1.78% | 1,280,450 | 79.76M |
| 362 | XNCR | Xencor, Inc. | 1.07B | 2.63% | 825,286 | 97.36M |
| 363 | AORT | Artivion, Inc. | 1.07B | 6.53% | 915,129 | 458.69M |
| 364 | CNMD | CONMED Corporation | 1.07B | 4.73% | 369,533 | 1.37B |
| 365 | SPRY | ARS Pharmaceuticals, Inc. | 1.05B | 2.53% | 1,254,176 | 98.99M |
| 366 | SPTX | Seaport Therapeutics, Inc. | 1.03B | 1.79% | 202,733 | - |
| 367 | TNDM | Tandem Diabetes Care, Inc. | 1.03B | 4.23% | 2,205,872 | 1.03B |
| 368 | NUTX | Nutex Health Inc. | 1.02B | 0.21% | 85,341 | 879.95M |
| 369 | BIOA | BioAge Labs, Inc. | 1.01B | 2.28% | 1,026,327 | 10.32M |
| 370 | AVR | Anteris Technologies Global Corp. | 1.01B | 1.17% | 1,620,413 | 1.85M |
| 371 | USPH | U.S. Physical Therapy, Inc. | 1.01B | 4.27% | 130,266 | 787.69M |
| 372 | CRON | Cronos Group Inc. | 1.00B | 0.74% | 1,033,385 | 159.54M |
| 373 | LXRX | Lexicon Pharmaceuticals, Inc. | 986.12M | 2.78% | 2,675,502 | 69.64M |
| 374 | SANA | Sana Biotechnology, Inc. | 983.67M | -2.09% | 2,508,802 | - |
| 375 | ORIC | ORIC Pharmaceuticals, Inc. | 976.17M | 5.84% | 1,290,572 | - |
| 376 | OLMA | Olema Pharmaceuticals, Inc. | 973.05M | 5.79% | 2,333,460 | - |
| 377 | EVO | Evotec SE | 971.12M | 2.29% | 21,810 | 859.03M |
| 378 | LMRI | Lumexa Imaging Holdings, Inc. | 958.89M | 5.83% | 495,429 | 1.03B |
| 379 | DBVT | DBV Technologies S.A. | 955.23M | -3.17% | 436,725 | 5.74M |
| 380 | AVTX | Avalo Therapeutics, Inc. | 954.59M | 1.85% | 1,286,853 | 59.00K |
| 381 | KURA | Kura Oncology, Inc. | 942.78M | 2.31% | 1,033,598 | 71.64M |
| 382 | PCRX | Pacira BioSciences, Inc. | 942.50M | 1.88% | 435,473 | 734.86M |
| 383 | INMD | InMode Ltd. | 937.08M | 10.79% | 3,476,282 | 374.64M |
| 384 | GDRX | GoodRx Holdings, Inc. | 934.74M | 3.37% | 915,661 | 787.89M |
| 385 | ETON | Eton Pharmaceuticals, Inc. | 930.79M | 1.46% | 446,006 | 86.93M |
| 386 | REPL | Replimune Group, Inc. | 930.59M | -1.31% | 2,861,481 | - |
| 387 | AMPH | Amphastar Pharmaceuticals, Inc. | 926.83M | 7.63% | 701,032 | 720.53M |
| 388 | PHAR | Pharming Group N.V. | 922.12M | 0.85% | 9,410 | 369.49M |
| 389 | SLDB | Solid Biosciences Inc. | 910.66M | 5.23% | 3,549,688 | - |
| 390 | DRTS | Alpha Tau Medical Ltd. | 906.27M | 2.55% | 604,244 | - |
| 391 | JANX | Janux Therapeutics, Inc. | 892.81M | -1.81% | 1,274,047 | 13.73M |
| 392 | TBPH | Theravance Biopharma, Inc. | 890.32M | 1.77% | 565,300 | 109.78M |
| 393 | GERN | Geron Corporation | 888.51M | 2.59% | 18,853,842 | 196.12M |
| 394 | ODTX | Odyssey Therapeutics, Inc. | 884.31M | -0.43% | 258,860 | 1.06M |
| 395 | ABUS | Arbutus Biopharma Corporation | 881.02M | 0.22% | 2,876,737 | 191.45M |
| 396 | ANRO | Alto Neuroscience, Inc. | 874.19M | 1.92% | 332,896 | - |
| 397 | LBRX | LB Pharmaceuticals Inc | 874.06M | -0.39% | 295,009 | - |
| 398 | TALK | Talkspace, Inc. | 869.39M | -0.19% | 2,910,702 | 238.37M |
| 399 | ANNX | Annexon, Inc. | 868.37M | 0.38% | 3,302,529 | - |
| 400 | DSGN | Design Therapeutics, Inc. | 860.66M | 0.29% | 790,347 | - |
| 401 | EVMN | Evommune, Inc. | 848.59M | -2.85% | 1,043,104 | 10.00M |
| 402 | CERT | Certara, Inc. | 844.72M | 0.56% | 2,386,556 | 419.75M |
| 403 | PHAT | Phathom Pharmaceuticals, Inc. | 842.75M | -2.30% | 899,733 | 204.89M |
| 404 | QDEL | QuidelOrtho Corporation | 832.61M | 2.30% | 1,526,367 | 2.66B |
| 405 | ESPR | Esperion Therapeutics, Inc. | 810.91M | -0.32% | 10,190,429 | 418.24M |
| 406 | BVS | Bioventus Inc. | 793.58M | 2.26% | 603,961 | 576.30M |
| 407 | VOR | Vor Biopharma Inc. | 784.61M | -2.49% | 659,905 | - |
| 408 | AURA | Aura Biosciences, Inc. | 776.51M | 0.28% | 396,993 | - |
| 409 | ZVRA | Zevra Therapeutics, Inc. | 773.23M | 0.62% | 982,970 | 122.29M |
| 410 | OMER | Omeros Corporation | 765.73M | 0.95% | 1,010,171 | 9.89M |
| 411 | HSTM | HealthStream, Inc. | 762.81M | 1.75% | 104,079 | 311.78M |
| 412 | GMRS | GMR Solutions Inc. | 734.02M | 2.03% | 581,939 | 5.83B |
| 413 | IVA | Inventiva S.A. | 733.72M | -6.74% | 1,094,061 | 7.94M |
| 414 | CLYM | Climb Bio, Inc. | 730.07M | 3.66% | 1,564,649 | - |
| 415 | SIBN | SI-BONE, Inc. | 724.67M | 2.45% | 457,203 | 206.22M |
| 416 | CTMX | CytomX Therapeutics, Inc. | 722.77M | 5.40% | 5,147,808 | 35.54M |
| 417 | IMMX | Immix Biopharma, Inc. | 714.75M | 1.31% | 1,903,466 | - |
| 418 | ALLO | Allogene Therapeutics, Inc. | 707.57M | -0.97% | 9,550,423 | 22.00K |
| 419 | CBLL | CeriBell, Inc. | 706.11M | 1.20% | 392,369 | 95.07M |
| 420 | SSII | SS Innovations International, Inc. | 704.46M | 3.53% | 44,400 | 48.47M |
| 421 | OCS | Oculis Holding AG | 698.09M | -1.37% | 367,545 | 1.40M |
| 422 | RLMD | Relmada Therapeutics, Inc. | 682.84M | -3.84% | 1,826,747 | - |
| 423 | CADL | Candel Therapeutics, Inc. | 679.22M | 2.09% | 1,467,796 | - |
| 424 | RIGL | Rigel Pharmaceuticals, Inc. | 676.25M | 2.64% | 274,461 | 299.77M |
| 425 | CSTL | Castle Biosciences, Inc. | 670.90M | 3.46% | 456,105 | 339.92M |
| 426 | NNNN | Anbio Biotechnology | 669.34M | -2.87% | 169,679 | 8.65M |
| 427 | ACRS | Aclaris Therapeutics, Inc. | 668.99M | -2.64% | 1,208,922 | 8.37M |
| 428 | TENX | Tenax Therapeutics, Inc. | 660.62M | -5.21% | 629,106 | - |
| 429 | CRMD | CorMedix Inc. | 658.21M | -2.44% | 1,382,331 | 400.05M |
| 430 | BBNX | Beta Bionics, Inc. | 656.39M | 7.75% | 1,481,216 | 110.24M |
| 431 | SGP | SpyGlass Pharma, Inc. | 655.83M | -0.25% | 79,684 | - |
| 432 | DRUG | Bright Minds Biosciences Inc. | 655.78M | 1.67% | 347,249 | - |
| 433 | NVCT | Nuvectis Pharma, Inc. | 649.35M | 39.49% | 1,277,235 | - |
| 434 | IRWD | Ironwood Pharmaceuticals, Inc. | 643.64M | 1.30% | 1,764,326 | 361.51M |
| 435 | DNA | Ginkgo Bioworks Holdings, Inc. | 635.61M | 9.82% | 1,081,683 | 151.40M |
| 436 | FTH | Faeth Therapeutics, Inc. | 634.16M | 2.50% | 102,819 | - |
| 437 | AQST | Aquestive Therapeutics, Inc. | 626.00M | -0.80% | 1,977,287 | 50.27M |
| 438 | TCMD | Tactile Systems Technology, Inc. | 619.28M | 3.80% | 152,286 | 343.52M |
| 439 | AGMB | AgomAb Therapeutics NV | 616.09M | 4.77% | 199,328 | - |
| 440 | FDMT | 4D Molecular Therapeutics, Inc. | 607.45M | 0.17% | 1,048,466 | 88.24M |
| 441 | SLBT | SL Science Holding Limited | 606.09M | -5.30% | 108,922 | - |
| 442 | MNPR | Monopar Therapeutics Inc. | 596.12M | 8.83% | 289,299 | - |
| 443 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 595.20M | -0.93% | 357,673 | - |
| 444 | PHR | Phreesia, Inc. | 592.78M | 4.81% | 1,129,871 | 495.59M |
| 445 | GYRE | Gyre Therapeutics, Inc. | 592.09M | 5.71% | 134,319 | 117.05M |
| 446 | BWAY | BrainsWay Ltd. | 583.27M | -0.28% | 52,019 | 56.22M |
| 447 | TRAX | First Tracks Biotherapeutics, Inc. | 582.35M | -6.13% | 405,294 | - |
| 448 | TECX | Tectonic Therapeutic, Inc. | 579.66M | 0.42% | 76,574 | - |
| 449 | CBIO | Crescent Biopharma, Inc. | 576.86M | -0.80% | 175,778 | 11.88M |
| 450 | ALT | Altimmune, Inc. | 573.70M | 1.37% | 3,097,917 | 36.00K |
| 451 | MDXG | MiMedx Group, Inc. | 570.46M | 2.68% | 834,795 | 389.42M |
| 452 | EVH | Evolent Health, Inc. | 565.78M | 4.79% | 1,835,922 | 1.89B |
| 453 | PRME | Prime Medicine, Inc. | 563.53M | -3.70% | 3,804,411 | 4.03M |
| 454 | NPCE | NeuroPace, Inc. | 553.00M | 1.88% | 155,489 | 99.53M |
| 455 | CTKB | Cytek Biosciences, Inc. | 552.73M | 5.16% | 1,488,768 | 204.17M |
| 456 | TLRY | Tilray Brands, Inc. | 547.51M | -0.43% | 2,844,410 | 858.28M |
| 457 | FLGT | Fulgent Genetics, Inc. | 543.30M | 5.23% | 206,565 | 320.35M |
| 458 | ACHV | Achieve Life Sciences, Inc. | 539.99M | 4.99% | 2,083,773 | - |
| 459 | ANGO | AngioDynamics, Inc. | 539.78M | 4.69% | 393,870 | 313.73M |
| 460 | CLPT | ClearPoint Neuro, Inc. | 539.21M | -2.97% | 573,842 | 40.61M |
| 461 | PROK | ProKidney Corp. | 534.65M | -1.67% | 558,379 | 889.00K |
| 462 | CERS | Cerus Corporation | 528.97M | 1.93% | 2,783,777 | 216.56M |
| 463 | XOMA | XOMA Royalty Corporation | 528.60M | 0.48% | 164,682 | 48.56M |
| 464 | RZLT | Rezolute, Inc. | 525.47M | 2.86% | 2,349,883 | - |
| 465 | TOI | The Oncology Institute, Inc. | 524.91M | 4.37% | 1,512,444 | 545.76M |
| 466 | KYTX | Kyverna Therapeutics, Inc. | 524.05M | 2.25% | 871,825 | - |
| 467 | EIKN | Eikon Therapeutics, Inc. | 521.35M | 1.26% | 256,531 | - |
| 468 | CTEV | Claritev Corporation | 519.79M | 1.43% | 154,044 | 978.76M |
| 469 | ARVN | Arvinas, Inc. | 519.40M | -1.11% | 674,613 | 89.40M |
| 470 | RGNX | REGENXBIO Inc. | 515.43M | 0.20% | 2,093,408 | 87.82M |
| 471 | ASMB | Assembly Biosciences, Inc. | 507.52M | -4.44% | 264,236 | 71.10M |
| 472 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 473 | VALN | Valneva SE | 498.24M | -3.15% | 6,963 | 180.25M |
| 474 | STRO | Sutro Biopharma, Inc. | 497.61M | 2.88% | 377,216 | 99.61M |
| 475 | CABA | Cabaletta Bio, Inc. | 494.06M | 0.33% | 2,995,671 | - |
| 476 | MYGN | Myriad Genetics, Inc. | 493.02M | 12.74% | 1,923,838 | 829.00M |
| 477 | PRTA | Prothena Corporation plc | 492.12M | -1.57% | 477,827 | 57.94M |
| 478 | KIDS | OrthoPediatrics Corp. | 491.61M | 4.16% | 168,663 | 243.30M |
| 479 | CTNM | Contineum Therapeutics, Inc. | 479.29M | 7.89% | 341,421 | - |
| 480 | SRTA | Strata Critical Medical, Inc. | 475.46M | -1.35% | 1,060,669 | 228.58M |
| 481 | NGNE | Neurogene Inc. | 475.16M | -2.56% | 130,923 | 925.00K |
| 482 | OCGN | Ocugen, Inc. | 470.55M | 0.72% | 6,531,885 | 4.47M |
| 483 | CCCC | C4 Therapeutics, Inc. | 469.91M | 0.71% | 2,735,381 | 34.86M |
| 484 | BNTC | Benitec Biopharma Inc. | 468.25M | 5.82% | 192,303 | - |
| 485 | OVID | Ovid Therapeutics Inc. | 466.60M | 7.76% | 2,799,602 | 7.12M |
| 486 | NRC | NRC Health | 466.51M | 3.29% | 87,926 | 138.64M |
| 487 | STTK | Shattuck Labs, Inc. | 460.85M | 11.50% | 1,241,390 | 1.00M |
| 488 | EOLS | Evolus, Inc. | 459.01M | 3.41% | 519,862 | 301.79M |
| 489 | SOPH | SOPHiA GENETICS SA | 454.39M | 5.54% | 195,381 | 81.18M |
| 490 | ARTV | Artiva Biotherapeutics, Inc. | 452.84M | -4.90% | 475,089 | 251.00K |
| 491 | FBRX | Forte Biosciences, Inc. | 451.82M | 1.87% | 217,028 | - |
| 492 | PACB | Pacific Biosciences of California, Inc. | 447.27M | 9.92% | 5,816,504 | 160.03M |
| 493 | VTVT | vTv Therapeutics Inc. | 443.52M | 1.17% | 60,208 | 36.84M |
| 494 | VMD | Viemed Healthcare, Inc. | 439.72M | 4.84% | 496,372 | 286.57M |
| 495 | VREX | Varex Imaging Corporation | 437.06M | -1.43% | 274,637 | 857.50M |
| 496 | ANL | Adlai Nortye Ltd. | 435.40M | 2.69% | 24,167 | 5.00M |
| 497 | EBS | Emergent BioSolutions Inc. | 434.96M | 5.24% | 891,724 | 676.80M |
| 498 | SLN | Silence Therapeutics plc | 432.66M | 26.00% | 2,224,979 | 839.00K |
| 499 | WEAV | Weave Communications, Inc. | 432.04M | -0.18% | 1,090,094 | 248.72M |
| 500 | MOBI | Mobia Medical, Inc. | 431.57M | -5.46% | 58,362 | 38.45M |